Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Lipidoid-coated iron oxide nanoparticles for efficient DNA and siRNA delivery.

Jiang S, Eltoukhy AA, Love KT, Langer R, Anderson DG.

Nano Lett. 2013 Mar 13;13(3):1059-64. doi: 10.1021/nl304287a. Epub 2013 Feb 14.

2.

Degradable polymer-coated gold nanoparticles for co-delivery of DNA and siRNA.

Bishop CJ, Tzeng SY, Green JJ.

Acta Biomater. 2015 Jan;11:393-403. doi: 10.1016/j.actbio.2014.09.020. Epub 2014 Sep 22.

3.

Gold, poly(beta-amino ester) nanoparticles for small interfering RNA delivery.

Lee JS, Green JJ, Love KT, Sunshine J, Langer R, Anderson DG.

Nano Lett. 2009 Jun;9(6):2402-6. doi: 10.1021/nl9009793.

4.

Lipid-like Nanoparticles for Small Interfering RNA Delivery to Endothelial Cells.

Cho SW, Goldberg M, Son SM, Xu Q, Yang F, Mei Y, Bogatyrev S, Langer R, Anderson DG.

Adv Funct Mater. 2009 Oct 9;19(19):3112-3118. Epub 2009 Aug 25.

5.

Engineering of small interfering RNA-loaded lipidoid-poly(DL-Lactic-Co-Glycolic Acid) hybrid nanoparticles for highly efficient and safe gene silencing: A quality by design-based approach.

Thanki K, Zeng X, Justesen S, Tejlmann S, Falkenberg E, Van Driessche E, Mørck Nielsen H, Franzyk H, Foged C.

Eur J Pharm Biopharm. 2017 Jul 26. pii: S0939-6411(17)30565-9. doi: 10.1016/j.ejpb.2017.07.014. [Epub ahead of print]

PMID:
28756280
6.

Synthesis of lipidic magnetic nanoparticles for nucleic acid delivery.

Namiki Y.

Methods Mol Biol. 2013;948:243-50. doi: 10.1007/978-1-62703-140-0_16.

PMID:
23070774
7.

Superparamagnetic iron oxide nanoparticles mediated (131)I-hVEGF siRNA inhibits hepatocellular carcinoma tumor growth in nude mice.

Chen J, Zhu S, Tong L, Li J, Chen F, Han Y, Zhao M, Xiong W.

BMC Cancer. 2014 Feb 21;14:114. doi: 10.1186/1471-2407-14-114.

8.

Multifunctional nanomedicine platform for cancer specific delivery of siRNA by superparamagnetic iron oxide nanoparticles-dendrimer complexes.

Taratula O, Garbuzenko O, Savla R, Wang YA, He H, Minko T.

Curr Drug Deliv. 2011 Jan;8(1):59-69. Review.

PMID:
21034421
9.

Enhanced intracellular siRNA delivery using bioreducible lipid-like nanoparticles.

Wang M, Alberti K, Varone A, Pouli D, Georgakoudi I, Xu Q.

Adv Healthc Mater. 2014 Sep;3(9):1398-403. doi: 10.1002/adhm.201400039. Epub 2014 Feb 20.

PMID:
24574196
10.

Lipid-based nanoparticles in the systemic delivery of siRNA.

Lin Q, Chen J, Zhang Z, Zheng G.

Nanomedicine (Lond). 2014 Jan;9(1):105-20. doi: 10.2217/nnm.13.192. Review.

PMID:
24354813
11.

Cell transcytosing poly-arginine coated magnetic nanovector for safe and effective siRNA delivery.

Veiseh O, Kievit FM, Mok H, Ayesh J, Clark C, Fang C, Leung M, Arami H, Park JO, Zhang M.

Biomaterials. 2011 Aug;32(24):5717-25. doi: 10.1016/j.biomaterials.2011.04.039. Epub 2011 May 13.

12.

Enhanced hepatic delivery of siRNA and microRNA using oleic acid based lipid nanoparticle formulations.

Wang X, Yu B, Ren W, Mo X, Zhou C, He H, Jia H, Wang L, Jacob ST, Lee RJ, Ghoshal K, Lee LJ.

J Control Release. 2013 Dec 28;172(3):690-8. doi: 10.1016/j.jconrel.2013.09.027. Epub 2013 Oct 8.

13.

Quantitation of physiological and biochemical barriers to siRNA liver delivery via lipid nanoparticle platform.

Xu Y, Ou M, Keough E, Roberts J, Koeplinger K, Lyman M, Fauty S, Carlini E, Stern M, Zhang R, Yeh S, Mahan E, Wang Y, Slaughter D, Gindy M, Raab C, Thompson C, Hochman J.

Mol Pharm. 2014 May 5;11(5):1424-34. doi: 10.1021/mp400584h. Epub 2014 Apr 1.

PMID:
24588618
14.

Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA.

Yang XZ, Dou S, Wang YC, Long HY, Xiong MH, Mao CQ, Yao YD, Wang J.

ACS Nano. 2012 Jun 26;6(6):4955-65. doi: 10.1021/nn300500u. Epub 2012 Jun 5.

PMID:
22646867
15.

Lipid nanoparticles for hepatic delivery of small interfering RNA.

Yu B, Hsu SH, Zhou C, Wang X, Terp MC, Wu Y, Teng L, Mao Y, Wang F, Xue W, Jacob ST, Ghoshal K, Lee RJ, Lee LJ.

Biomaterials. 2012 Sep;33(25):5924-34. doi: 10.1016/j.biomaterials.2012.05.002. Epub 2012 May 29.

16.

A novel local anti-colorectal cancer drug delivery system: negative lipidoid nanoparticles with a passive target via a size-dependent pattern.

Ding W, Wang F, Zhang J, Guo Y, Ju S, Wang H.

Nanotechnology. 2013 Sep 20;24(37):375101. doi: 10.1088/0957-4484/24/37/375101. Epub 2013 Aug 21.

PMID:
23965897
17.

Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.

Gomes-da-Silva LC, Fonseca NA, Moura V, Pedroso de Lima MC, Simões S, Moreira JN.

Acc Chem Res. 2012 Jul 17;45(7):1163-71. doi: 10.1021/ar300048p. Epub 2012 May 8.

PMID:
22568781
18.

Micelle-like nanoparticles as carriers for DNA and siRNA.

Navarro G, Pan J, Torchilin VP.

Mol Pharm. 2015 Feb 2;12(2):301-13. doi: 10.1021/mp5007213. Epub 2015 Jan 12. Review.

19.

Subtle changes to polymer structure and degradation mechanism enable highly effective nanoparticles for siRNA and DNA delivery to human brain cancer.

Tzeng SY, Green JJ.

Adv Healthc Mater. 2013 Mar;2(3):468-80. doi: 10.1002/adhm.201200257. Epub 2012 Sep 26.

20.

N-Alkyl-PEI-functionalized iron oxide nanoclusters for efficient siRNA delivery.

Liu G, Xie J, Zhang F, Wang Z, Luo K, Zhu L, Quan Q, Niu G, Lee S, Ai H, Chen X.

Small. 2011 Oct 4;7(19):2742-9. doi: 10.1002/smll.201100825. Epub 2011 Aug 22. Erratum in: Small. 2011 Dec 2;7(23):3260.

Supplemental Content

Support Center